Home Other Building Blocks 1080-44-0
1080-44-0,MFCD03092531
Catalog No.:AA00844A

1080-44-0 | N-P-Tosylglycine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5g
97%
in stock  
$13.00   $9.00
- +
10g
97%
in stock  
$24.00   $17.00
- +
25g
>90%(HPLC)
in stock  
$48.00   $34.00
- +
100g
>90%(HPLC)
in stock  
$120.00   $84.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00844A
Chemical Name:
N-P-Tosylglycine
CAS Number:
1080-44-0
Molecular Formula:
C9H11NO4S
Molecular Weight:
229.2529
MDL Number:
MFCD03092531
SMILES:
OC(=O)CNS(=O)(=O)c1ccc(cc1)C
NSC Number:
25821
Properties
Computed Properties
 
Complexity:
312  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
15  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
4  
XLogP3:
0.8  

Upstream Synthesis Route

[1]EuropeanJournalofMedicinalChemistry,2017,vol.135,p.349-369

[2]PLoSONE,2018,vol.13,#1,

[3]JournaloftheAmericanChemicalSociety,2018,vol.140,#17,p.5834-5841

[4]JournalofMolecularCatalysisA:Chemical,2011,vol.351,p.41-45

[5]OrganicandBiomolecularChemistry,2018,vol.16,#31,p.5618-5625

[6]CatalysisCommunications,2011,vol.12,#15,p.1477-1482

[7]EuropeanJournalofOrganicChemistry,2007,#35,p.5909-5916

[8]ACSCombinatorialScience,2013,vol.15,#5,p.235-239

[9]BioorganicandMedicinalChemistryLetters,2014,vol.24,#15,p.3422-3425

[10]ZeitschriftfurNaturforschung-SectionBJournalofChemicalSciences,2000,vol.55,#2,p.203-207

[11]AdvancedSynthesisandCatalysis,2007,vol.349,#11-12,p.1873-1876

[12]BioorganicandMedicinalChemistry,2015,vol.23,#23,p.7353-7358

[13]Synthesis(Germany),2016,vol.48,#21,p.3719-3729

[14]IndianJournalofChemistry-SectionBOrganicandMedicinalChemistry,2002,vol.41,#12,p.2635-2641

[15]AsianJournalofChemistry,2013,vol.25,#8,p.4401-4403

[16]AgriculturalandBiologicalChemistry,1985,vol.49,#4,p.973-980

[17]JournalofPharmaceuticalSciences,1987,vol.76,#2,p.149-152

[18]Patent:WO2007/136858,2007,A2,.Locationinpatent:Page/Pagecolumn66

[19]JustusLiebigsAnnalenderChemie,1913,vol.398,p.118

[20]JournaloftheAmericanChemicalSociety,1937,vol.59,p.1116

[21]ChemicalandPharmaceuticalBulletin,1982,vol.30,#9,p.3244-3254

[22]BulletinoftheChemicalSocietyofJapan,1996,vol.69,#12,p.3639-3650

[23]EuropeanJournalofMedicinalChemistry,2000,vol.35,#3,p.299-307

[24]TetrahedronLetters,2001,vol.42,#4,p.665-667

[25]HeteroatomChemistry,2002,vol.13,#4,p.316-323

[26]OrganicLetters,2006,vol.8,#4,p.633-636

[27]Patent:US2002/151546,2002,A1,

[28]JournalofCoordinationChemistry,2011,vol.64,#10,p.1695-1706

[29]OrganicandBiomolecularChemistry,2012,vol.10,#9,p.1735-1738

[30]JournalofCoordinationChemistry,2012,vol.65,#2,p.239-250

[31]JournalofCoordinationChemistry,2012,vol.65,#18,p.3160-3173

[32]OrganicLetters,2016,vol.18,#4,p.740-743

[33]BioorganicandMedicinalChemistry,2016,vol.24,#11,p.2567-2575

[34]AdvancedSynthesisandCatalysis,2016,vol.358,#9,p.1385-1391

[35]AdvancedSynthesisandCatalysis,2016,vol.358,#12,p.1968-1974

[36]SyntheticCommunications,2016,vol.46,#15,p.1299-1306

[37]PLoSONE,2017,vol.12,#9,

[38]EuropeanJournalofOrganicChemistry,2018,vol.2018,#8,p.1067-1070

[39]EuropeanJournalofMedicinalChemistry,2018,vol.150,p.87-101

[40]LipidsinHealthandDisease,2018,vol.17,#1,

[1]ACSMedicinalChemistryLetters,2015,vol.6,#9,p.982-986

[1]ChemicalCommunications,2003,#22,p.2838-2839

[1]ACSMedicinalChemistryLetters,2015,vol.6,#9,p.982-986

[1]AngewandteChemie,1926,vol.39,p.1460

[2]Chem.Zentralbl.,1930,vol.101,#I,p.3485

[3]Fortschr.Teerfarbenfabr.Verw.Industriezweige,vol.16,p.293

Downstream Synthesis Route

[1]OrganicLetters,2019,vol.21,p.1098-1102

[2]Patent:WO2006/123257,2006,A2.Locationinpatent:Page/Pagecolumn77

[3]JournalofHeterocyclicChemistry,1991,vol.28,p.1671-1676

[4]ChemischeBerichte,1956,vol.89,p.1674,1679

[5]JustusLiebigsAnnalenderChemie,1961,vol.640,p.136-139

[1]EuropeanJournalofMedicinalChemistry,2018,vol.150,p.87-101

[2]ActaUniversitatesLundensis28<1892>,2.Abt.,Abhandl.III,S.12,

[1]Patent:WO2007/136858,2007,A2.Locationinpatent:Page/Pagecolumn66

[2]JournaloftheAmericanChemicalSociety,1952,vol.74,p.470,473

[3]Hoppe-Seyler'sZeitschriftfurPhysiologischeChemie,1926,vol.154,p.223

[4]ChemischeBerichte,1961,vol.94,p.527-537

[5]Pharmazie,1984,vol.39,p.226-230

[6]Pharmazie,1981,vol.36,p.668-671

[7]JournaloftheChemicalSociety.PerkintransactionsI,1998,p.1919-1923

[8]HeteroatomChemistry,2003,vol.14,p.247-253

[9]OrganicLetters,2016,vol.18,p.740-743

[10]EuropeanJournalofOrganicChemistry,2018,vol.2018,p.1067-1070

[11]JournalofOrganicChemistry,2019,vol.84,p.12773-12783

[1],1892,vol.28,p.2.Abt.,Abhandl.III,S.3

[2]OrganicLetters,2020

[1]EuropeanJournalofMedicinalChemistry,2017,vol.135,p.349-369

[2]PLoSONE,2018,vol.13

[3]JournaloftheAmericanChemicalSociety,2018,vol.140,p.5834-5841

[4]JournalofMolecularCatalysisA:Chemical,2011,vol.351,p.41-45

[5]OrganicandBiomolecularChemistry,2018,vol.16,p.5618-5625

[6]CatalysisCommunications,2011,vol.12,p.1477-1482

[7]EuropeanJournalofOrganicChemistry,2007,p.5909-5916

[8]ACSCombinatorialScience,2013,vol.15,p.235-239

[9]BioorganicandMedicinalChemistryLetters,2014,vol.24,p.3422-3425

[10]ZeitschriftfurNaturforschung,B:ChemicalSciences,2000,vol.55,p.203-207

[11]AdvancedSynthesisandCatalysis,2007,vol.349,p.1873-1876

[12]BioorganicandMedicinalChemistry,2015,vol.23,p.7353-7358

[13]OrganicLetters,2019,vol.21,p.1098-1102

[14]Synthesis,2016,vol.48,p.3719-3729

[15]IndianJournalofChemistry-SectionBOrganicandMedicinalChemistry,2002,vol.41,p.2635-2641

[16]AsianJournalofChemistry,2013,vol.25,p.4401-4403

[17]AgriculturalandBiologicalChemistry,1985,vol.49,p.973-980

[18]JournalofPharmaceuticalSciences,1987,vol.76,p.149-152

[19]JournalofMedicinalChemistry,2020,vol.63,p.5139-5158

[20]Patent:WO2007/136858,2007,A2.Locationinpatent:Page/Pagecolumn66

[21]JustusLiebigsAnnalenderChemie,1913,vol.398,p.118

[22]JournaloftheAmericanChemicalSociety,1937,vol.59,p.1116

[23]ChemicalandPharmaceuticalBulletin,1982,vol.30,p.3244-3254

[24]BulletinoftheChemicalSocietyofJapan,1996,vol.69,p.3639-3650

[25]EuropeanJournalofMedicinalChemistry,2000,vol.35,p.299-307

[26]TetrahedronLetters,2001,vol.42,p.665-667

[27]HeteroatomChemistry,2002,vol.13,p.316-323

[28]OrganicLetters,2006,vol.8,p.633-636

[29]Patent:US2002/151546,2002,A1

[30]JournalofCoordinationChemistry,2011,vol.64,p.1695-1706

[31]OrganicandBiomolecularChemistry,2012,vol.10,p.1735-1738

[32]JournalofCoordinationChemistry,2012,vol.65,p.239-250

[33]JournalofCoordinationChemistry,2012,vol.65,p.3160-3173

[34]OrganicLetters,2016,vol.18,p.740-743

[35]BioorganicandMedicinalChemistry,2016,vol.24,p.2567-2575

[36]AdvancedSynthesisandCatalysis,2016,vol.358,p.1385-1391

[37]AdvancedSynthesisandCatalysis,2016,vol.358,p.1968-1974

[38]SyntheticCommunications,2016,vol.46,p.1299-1306

[39]PLoSONE,2017,vol.12

[40]EuropeanJournalofOrganicChemistry,2018,vol.2018,p.1067-1070

[41]EuropeanJournalofMedicinalChemistry,2018,vol.150,p.87-101

[42]LipidsinHealthandDisease,2018,vol.17

[43]EuropeanJournalofOrganicChemistry,2018,vol.2018,p.5905-5909

[44]JournalofOrganicChemistry,2019,vol.84,p.12773-12783

Literature

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Title: Aqua-{N-[(4-methyl-phen-yl)sulfon-yl]glycinato(2-)-κN,O}(1,10-phenan-throline)copper(II).

Journal: Acta crystallographica. Section E, Structure reports online 20101001

Title: Reactions of glycidyl derivatives with ambident nucleophiles; part 2: amino acid derivatives.

Journal: Beilstein journal of organic chemistry 20070101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:1080-44-0 Molecular Formula|1080-44-0 MDL|1080-44-0 SMILES|1080-44-0 N-P-Tosylglycine